The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...
As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...
Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of ...
Two former Pfizer executives said they will not be involved with activist investor Starboard Value, which reportedly wants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback